- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/28 - 1-(4-Chlorobenzoyl)-2-methyl- indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atomEsters thereof
Patent holdings for IPC class C07D 209/28
Total number of patents in this class: 25
10-year publication summary
|
1
|
3
|
0
|
3
|
3
|
2
|
2
|
0
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Kyushu University, National University Corporation | 1725 |
2 |
| Soochow University | 1785 |
2 |
| Risen (Suzhou) Pharma Tech Co., Ltd. | 73 |
2 |
| Shanghai Junshi Biosciences Co., Ltd. | 110 |
2 |
| NGK Insulators, Ltd. | 5241 |
1 |
| Augusta University Research Institute, Inc. | 150 |
1 |
| Cedars-Sinai Medical Center | 1209 |
1 |
| Daiichi Sankyo Company, Limited | 1890 |
1 |
| EMS S.A. | 16 |
1 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 128 |
1 |
| Lehigh University | 172 |
1 |
| Medrx Co., Ltd. | 126 |
1 |
| Nanoegg Research Laboratories, Inc. | 21 |
1 |
| The Penn State Research Foundation | 1615 |
1 |
| Piramal Enterprises Limited | 151 |
1 |
| Rutgers, The State University of New Jersey | 1975 |
1 |
| Universidade Estadual Paulista Julio de Mesquita Filho - Unesp | 36 |
1 |
| Lunella Biotech, Inc. | 102 |
1 |
| Ripple Therapeutics Corporation | 41 |
1 |
| Shenzhen Fushan Biotec Co.,Ltd | 1 |
1 |
| Other owners | 1 |